The subject of this Contract is the clinical assessment of the compound REGN727/SAR236553 in accordance with the protocol enclosed hereto as Appendix No.1 entitled ““AN OPEN-LABEL STUDY OF DUPILUMAB IN PATIENTS WITH ATOPIC DERMATITIS WHO PARTICIPATED...
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://smlouvy.gov.cz/smlouva/soubor/2886562/Klinicke_hodnoceni_Regeneron_Prahrmaceuticals.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
